For the year ending 2025-12-31, CAI has $1,125,663K in assets. $548,356K in debts.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash, cash equivalents, and restricted cash | 797,799 | |||
| Short-term marketable securities | 2,295 | |||
| Accounts receivable | 112,140 | |||
| Supplies | 63,625 | |||
| Prepaid expenses and other current assets | 21,941 | |||
| Total current assets | 997,800 | |||
| Property and equipment, net | 63,170 | |||
| Goodwill | 19,344 | |||
| Other assets | 45,349 | |||
| Total assets | 1,125,663 | |||
| Accounts payable | 39,206 | |||
| Accrued expenses and other current liabilities | 87,770 | |||
| Current portion of indebtedness | 169 | |||
| Total current liabilities | 127,145 | |||
| Long-term indebtedness, net of debt discounts | 378,823 | |||
| Warrant liabilities | 0 | |||
| Other long-term liabilities | 42,388 | |||
| Total liabilities | 548,356 | |||
| Redeemable convertible preferred stock-Series APreferred Stock | 0 | |||
| Redeemable convertible preferred stock-Series BPreferred Stock | 0 | |||
| Redeemable convertible preferred stock-Series CPreferred Stock | 0 | |||
| Redeemable convertible preferred stock-Series DPreferred Stock | 0 | |||
| Redeemable convertible preferred stock | 0 | |||
| Preferred stock | 0 | |||
| Common stock | 283 | |||
| Treasury stock | 16,896 | |||
| Additional paid-in capital | 3,141,720 | |||
| Related party promissory note receivable (see note 7) | 0 | |||
| Accumulated deficit | -2,548,736 | |||
| Accumulated other comprehensive income | 936 | |||
| Total shareholders' equity (deficit) | 577,307 | |||
| Total liabilities, redeemable convertible preferred stock, and shareholders' equity (deficit) | 1,125,663 | |||
Caris Life Sciences, Inc. (CAI)
Caris Life Sciences, Inc. (CAI)